Bromocriptine Mesylate Tablet
Product Images NDC 0574-0106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 0574-0106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-30ct (Carton 30ct)

Label for Bromocriptine Mesylate Tablets USP 2.5 mg oral tablets by Padagis US LLC, containing 30 tablets. The label includes storage instructions to keep between 20° to 25°C and dispensing information about using a child-resistant closure. The manufacturer is Perrigo, Minneapolis, MN. The NDC on the label is 0574-0106-03.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Bromocriptine mesylate showing its molecular formula C32H40BrN5O5 with the mesylate (CH4SO3) group and molecular weight of 750.70.*

FDA Label Image

Serialization-template-1 (Image 02)

The image shows a product label placeholder with fields for serial number, lot number, and expiration date, used for Bromocriptine mesylate 2.5 mg oral tablets by Padagis US LLC. The label format includes placeholders for serialization (S/N), lot, and expiration (Exp) information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.